All 1 tracked stories fall under one category: market-trends. Aerogel is most often covered alongside Anni Seaborne, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Aerogel
All 1 tracked stories fall under one category: market-trends. Aerogel is most often covered alongside Anni Seaborne, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. Their average consequence score of 5 runs below the beat's 5.2 for that window. We currently track 1 Healthcare story that mention Aerogel, all published on August 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Aerogel. Shared-story counts are live from our verified record — not editorial picks.
A 10-year development effort by NHS maxillofacial surgeon Dr Niall Kent produced Ozen, an aerogel-based toothpaste that seals dentinal channels and releases remineralizing ions — the first new sensitivity patent in nearly three decades. Claims of instant relief are winning endorsement from high-profile sports dentistry but remain unverified by published clinical trials.